ECM
MRNA icon

ExodusPoint Capital Management’s Moderna MRNA Stock Holding History

ExodusPoint Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,800
Closed -$3.66M – 1914
2024
Q2 		$3.66M Buy
+30,800
New +$3.9M 0.02% 542

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ExodusPoint Capital Management's MRNA Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its Moderna (MRNA) stake by 66% in Q1 2026, selling an estimated $1.19M and leaving 13,099 shares worth $665K. The position accounts for 0.01% of the portfolio, ranked #1114.

ExodusPoint Capital Management first reported a position in MRNA in Q1 2020 and has held it in 15 quarters since. The position peaked at $79.1M in Q2 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • ExodusPoint Capital Management held 13,099 shares of Moderna worth $665K as of Q1 2026.
  • ExodusPoint Capital Management sold 25,606 Moderna shares in Q1 2026, an estimated $1.19M.
  • Moderna made up 0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #1114 holding.
  • ExodusPoint Capital Management first reported a position in Moderna in Q1 2020 and has held it in 15 quarters since.
  • ExodusPoint Capital Management's Moderna position peaked at $79.1M in Q2 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.